Skip to main content
Top
Published in: Infection 1/2013

01-02-2013 | Clinical and Epidemiological Study

Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience

Authors: W. Kwon, J.-Y. Jang, E.-C. Kim, J. W. Park, I. W. Han, M. J. Kang, S.-W. Kim

Published in: Infection | Issue 1/2013

Login to get access

Abstract

Purpose

Rapidly changing medical environments may have changed the microbiology of infected bile. The aim of our study was to identify the changing trends in microorganisms in biliary infections and examine their susceptibilities against currently recommended antibiotics.

Methods

Bile cultures taken between 1998 and 2010 at Seoul National University Hospital, a tertiary medical center, were retrospectively reviewed. From 1,403 patients, 3,425 microorganisms were isolated from 2,217 cultures. The cultures were then tested to determine the types of microorganisms and their antibiotic susceptibility.

Results

The five most frequently isolated microorganisms were Enterococcus (22.7 %) followed by Escherichia (13.2 %), Pseudomonas (10.9 %), Klebsiella (10.3 %), and Enterobacter (7.2 %). The trend in annual incidence indicated a growing emergence of Enterococcus (P < 0.001). Among Enterococcus, E. faecium acquired a dominant position (50.6 %), showing an increasing trend over the study period (P = 0.026). The incidence of vancomycin-resistant Enterococcus also showed an increasing trend (P < 0.001). Many of the commonly used antibiotics provided inadequate coverage for the more frequently encountered microorganisms. Multiple regression revealed that benign causes of obstruction and non-operative treatment harbor an increased risk for enterococcal growth (P = 0.001 and P = 0.027, respectively).

Conclusions

In contrast to earlier reports, we found that Enterococcus has emerged as the most frequently isolated microorganism from bile. The importance of enterococcal infection should be recognized, and currently recommended antibiotics need to be re-evaluated since in our bile cultures most provided inadequate coverage for the more frequently encountered microorganisms. The changes in the trends of microorganisms isolated from bile should be considered in cases where patients present with biliary obstruction.
Literature
1.
go back to reference Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin N Am. 1990;70:1297–312.PubMed Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin N Am. 1990;70:1297–312.PubMed
2.
go back to reference Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc. 1994;40:716–21.PubMed Leung JW, Ling TK, Chan RC, Cheung SW, Lai CW, Sung JJ, et al. Antibiotics, biliary sepsis, and bile duct stones. Gastrointest Endosc. 1994;40:716–21.PubMed
4.
go back to reference Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology. 1989;36:132–5.PubMed Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology. 1989;36:132–5.PubMed
5.
go back to reference Dowidar N, Kolmos HJ, Lyon H, Matzen P. Clogging of biliary endoprostheses. A morphologic and bacteriologic study. Scand J Gastroenterol. 1991;26:1137–44.PubMedCrossRef Dowidar N, Kolmos HJ, Lyon H, Matzen P. Clogging of biliary endoprostheses. A morphologic and bacteriologic study. Scand J Gastroenterol. 1991;26:1137–44.PubMedCrossRef
6.
go back to reference Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier; 2010. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier; 2010.
7.
go back to reference Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 17th informational supplement. In: Institute CaLS, editor. CLSI document M100S17. Wayne: Clinical and Laboratory Standard Institute; 2007. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 17th informational supplement. In: Institute CaLS, editor. CLSI document M100S17. Wayne: Clinical and Laboratory Standard Institute; 2007.
8.
go back to reference Fukunaga FH. Gallbladder bacteriology, histology, and gallstones. Study of unselected cholecystectomy specimens in Honolulu. Arch Surg. 1973;106:169–71.PubMedCrossRef Fukunaga FH. Gallbladder bacteriology, histology, and gallstones. Study of unselected cholecystectomy specimens in Honolulu. Arch Surg. 1973;106:169–71.PubMedCrossRef
10.
go back to reference Suzuki Y, Kobayashi A, Ohto M, Tsuchiya Y, Saisho H, Kimura K, et al. Bacteriological study of transhepatically aspirated bile. Relation to cholangiographic findings in 295 patients. Dig Dis Sci. 1984;29:109–15.PubMedCrossRef Suzuki Y, Kobayashi A, Ohto M, Tsuchiya Y, Saisho H, Kimura K, et al. Bacteriological study of transhepatically aspirated bile. Relation to cholangiographic findings in 295 patients. Dig Dis Sci. 1984;29:109–15.PubMedCrossRef
11.
12.
go back to reference Bae WK, Moon YS, Kim JH, Lee SH, Kim NH, Kim KA, et al. Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection. Korean J Gastroenterol. 2008;51:248–54.PubMed Bae WK, Moon YS, Kim JH, Lee SH, Kim NH, Kim KA, et al. Microbiologic study of the bile culture and antimicrobial susceptibility in patients with biliary tract infection. Korean J Gastroenterol. 2008;51:248–54.PubMed
13.
go back to reference Li QW, Ji F. A clinical study of bile cultures and antibiotic susceptibility test in the patients with operation on biliary tract. Zhonghua Wai Ke Za Zhi. 2009;47:527–9.PubMed Li QW, Ji F. A clinical study of bile cultures and antibiotic susceptibility test in the patients with operation on biliary tract. Zhonghua Wai Ke Za Zhi. 2009;47:527–9.PubMed
14.
go back to reference Salvador VB, Lozada MC, Consunji RJ. Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center. Surg Infect (Larchmt). 2011;12:105–11. doi:10.1089/sur.2010.005.CrossRef Salvador VB, Lozada MC, Consunji RJ. Microbiology and antibiotic susceptibility of organisms in bile cultures from patients with and without cholangitis at an Asian academic medical center. Surg Infect (Larchmt). 2011;12:105–11. doi:10.​1089/​sur.​2010.​005.CrossRef
15.
go back to reference Karpel E, Madej A, Buldak L, Dulawa-Buldak A, Nowakowska-Dulawa E, Labuzek K, et al. Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis. Scand J Gastroenterol. 2011;46:925–30. doi:10.3109/00365521.2011.560676.PubMedCrossRef Karpel E, Madej A, Buldak L, Dulawa-Buldak A, Nowakowska-Dulawa E, Labuzek K, et al. Bile bacterial flora and its in vitro resistance pattern in patients with acute cholangitis resulting from choledocholithiasis. Scand J Gastroenterol. 2011;46:925–30. doi:10.​3109/​00365521.​2011.​560676.PubMedCrossRef
16.
go back to reference Flores C, Maguilnik I, Hadlich E, Goldani LZ. Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. J Gastroenterol Hepatol. 2003;18:333–6.PubMedCrossRef Flores C, Maguilnik I, Hadlich E, Goldani LZ. Microbiology of choledochal bile in patients with choledocholithiasis admitted to a tertiary hospital. J Gastroenterol Hepatol. 2003;18:333–6.PubMedCrossRef
18.
go back to reference Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc. 2002;56:885–9. doi:10.1067/mge.2002.129604.PubMedCrossRef Rerknimitr R, Fogel EL, Kalayci C, Esber E, Lehman GA, Sherman S. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis. Gastrointest Endosc. 2002;56:885–9. doi:10.​1067/​mge.​2002.​129604.PubMedCrossRef
19.
go back to reference Nomura T, Shirai Y, Hatakeyama K. Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction. Dig Dis Sci. 1999;44:542–6.PubMedCrossRef Nomura T, Shirai Y, Hatakeyama K. Bacteribilia and cholangitis after percutaneous transhepatic biliary drainage for malignant biliary obstruction. Dig Dis Sci. 1999;44:542–6.PubMedCrossRef
20.
go back to reference Yu H, Guo Z, Xing W, Guo X, Liu F, Li B. Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Intervent Radiol. 2012;35:1136–44. doi:10.1007/s00270-011-0263-2. Yu H, Guo Z, Xing W, Guo X, Liu F, Li B. Bile culture and susceptibility testing of malignant biliary obstruction via PTBD. Cardiovasc Intervent Radiol. 2012;35:1136–44. doi:10.​1007/​s00270-011-0263-2.
22.
go back to reference Nomura T, Shirai Y, Hatakeyama K. Enterococcal bactibilia in patients with malignant biliary obstruction. Dig Dis Sci. 2000;45:2183–6.PubMedCrossRef Nomura T, Shirai Y, Hatakeyama K. Enterococcal bactibilia in patients with malignant biliary obstruction. Dig Dis Sci. 2000;45:2183–6.PubMedCrossRef
23.
go back to reference Bryan CS, Reynolds KL, Brown JJ. Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet. 1985;160:557–61.PubMed Bryan CS, Reynolds KL, Brown JJ. Mortality associated with enterococcal bacteremia. Surg Gynecol Obstet. 1985;160:557–61.PubMed
24.
go back to reference McBride SJ, Upton A, Roberts SA. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review. Eur J Clin Microbiol Infect Dis. 2010;29:107–14. doi:10.1007/s10096-009-0830-5.PubMedCrossRef McBride SJ, Upton A, Roberts SA. Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia—a five-year retrospective review. Eur J Clin Microbiol Infect Dis. 2010;29:107–14. doi:10.​1007/​s10096-009-0830-5.PubMedCrossRef
25.
go back to reference Caballero-Granado FJ, Becerril B, Cuberos L, Bernabeu M, Cisneros JM, Pachon J. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis. 2001;32:587–94. doi:10.1086/318717.PubMedCrossRef Caballero-Granado FJ, Becerril B, Cuberos L, Bernabeu M, Cisneros JM, Pachon J. Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia. Clin Infect Dis. 2001;32:587–94. doi:10.​1086/​318717.PubMedCrossRef
26.
go back to reference Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91:S72–5.CrossRef Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991;91:S72–5.CrossRef
27.
go back to reference Bush LM, Calmon J, Cherney CL, Wendeler M, Pitsakis P, Poupard J, et al. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med. 1989;110:515–20.PubMed Bush LM, Calmon J, Cherney CL, Wendeler M, Pitsakis P, Poupard J, et al. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections. Ann Intern Med. 1989;110:515–20.PubMed
28.
go back to reference Patterson JE, Zervos MJ. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis. 1990;12:644–52.PubMedCrossRef Patterson JE, Zervos MJ. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis. 1990;12:644–52.PubMedCrossRef
29.
30.
go back to reference DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41:327–33. doi:10.1086/430909.PubMedCrossRef DiazGranados CA, Zimmer SM, Klein M, Jernigan JA. Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis. 2005;41:327–33. doi:10.​1086/​430909.PubMedCrossRef
31.
go back to reference Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis. 2000;36:145–58.PubMedCrossRef Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. Diagn Microbiol Infect Dis. 2000;36:145–58.PubMedCrossRef
32.
go back to reference Thompson J, Bennion RS, Pitt HA. An analysis of infectious failures in acute cholangitis. HPB Surg. 1994;8:139–44. (discussion 45).PubMedCrossRef Thompson J, Bennion RS, Pitt HA. An analysis of infectious failures in acute cholangitis. HPB Surg. 1994;8:139–44. (discussion 45).PubMedCrossRef
33.
go back to reference Yellin AE, Heseltine PN, Berne TV, Appleman MD, Gill MA, Riggio CE, et al. The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet. 1985;161:303–7.PubMed Yellin AE, Heseltine PN, Berne TV, Appleman MD, Gill MA, Riggio CE, et al. The role of Pseudomonas species in patients treated with ampicillin and sulbactam for gangrenous and perforated appendicitis. Surg Gynecol Obstet. 1985;161:303–7.PubMed
34.
go back to reference Walker AP, Nichols RL, Wilson RF, Bivens BA, Trunkey DD, Edmiston CE Jr, et al. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections. Ann Surg. 1993;217:115–21.PubMedCrossRef Walker AP, Nichols RL, Wilson RF, Bivens BA, Trunkey DD, Edmiston CE Jr, et al. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections. Ann Surg. 1993;217:115–21.PubMedCrossRef
35.
go back to reference Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O’Marro S, et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg. 2000;232:254–62.PubMedCrossRef Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O’Marro S, et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg. 2000;232:254–62.PubMedCrossRef
37.
go back to reference Sirinek KR, Levine BA. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis. Surg Gynecol Obstet. 1991;172:30–5.PubMed Sirinek KR, Levine BA. A randomized trial of ticarcillin and clavulanate versus gentamicin and clindamycin in patients with complicated appendicitis. Surg Gynecol Obstet. 1991;172:30–5.PubMed
38.
go back to reference Polk HC Jr, Fink MP, Laverdiere M, Wilson SE, Garber GE, Barie PS, et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The piperacillin/tazobactam intra-abdominal infection study group. Am Surg. 1993;59:598–605.PubMed Polk HC Jr, Fink MP, Laverdiere M, Wilson SE, Garber GE, Barie PS, et al. Prospective randomized study of piperacillin/tazobactam therapy of surgically treated intra-abdominal infection. The piperacillin/tazobactam intra-abdominal infection study group. Am Surg. 1993;59:598–605.PubMed
39.
go back to reference Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997–1005. doi:10.1086/378702.PubMedCrossRef Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, et al. Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997–1005. doi:10.​1086/​378702.PubMedCrossRef
41.
go back to reference Marne C, Pallares R, Martin R, Sitges-Serra A. Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile. Eur J Clin Microbiol. 1986;5:35–9.PubMedCrossRef Marne C, Pallares R, Martin R, Sitges-Serra A. Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile. Eur J Clin Microbiol. 1986;5:35–9.PubMedCrossRef
42.
go back to reference van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279–86.PubMedCrossRef van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. 1994;19:279–86.PubMedCrossRef
43.
go back to reference Gilbert DN, Moellering RC, Eliopoulis GM, Saag MS, Chambers HF. The Sanford guide to antimicrobial therapy 2011. 39th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2011. Gilbert DN, Moellering RC, Eliopoulis GM, Saag MS, Chambers HF. The Sanford guide to antimicrobial therapy 2011. 39th ed. Sperryville, VA: Antimicrobial Therapy Inc; 2011.
44.
go back to reference Negm AA, Schott A, Vonberg R-P, Weismueller TJ, Schneider AS, Kubicka S, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc. 2010;72:284–91. doi:10.1016/j.gie.2010.02.043.PubMedCrossRef Negm AA, Schott A, Vonberg R-P, Weismueller TJ, Schneider AS, Kubicka S, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc. 2010;72:284–91. doi:10.​1016/​j.​gie.​2010.​02.​043.PubMedCrossRef
Metadata
Title
Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience
Authors
W. Kwon
J.-Y. Jang
E.-C. Kim
J. W. Park
I. W. Han
M. J. Kang
S.-W. Kim
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
Infection / Issue 1/2013
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-012-0358-y

Other articles of this Issue 1/2013

Infection 1/2013 Go to the issue